20 results
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
7:03am
product into the ongoing Phase 1 clinical trial
Strong Financial Position $329M includes funds as of August 31, 2023, and $60M from Pfizer deal R&D collaboration
8-K
EX-99.1
rbz8gp
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
54usf
26 May 22
Other Events
7:02am
8-K
EX-99.2
986296ud oqc
26 May 22
Other Events
7:02am
8-K
EX-99.1
hkmc56mtvxw247q 4o
26 May 22
Other Events
7:02am
8-K
EX-99.1
gq8stc4z q6
10 Jan 22
Other Events
7:11am
10-K
nt5rwc3
16 Feb 21
Annual report
4:11pm
10-Q
ad7ur2nupeh6crh9he
14 Oct 20
Quarterly report
4:02pm
S-1
EX-10.9
2um5qwqqcl7
2 Jul 20
IPO registration
4:04pm
DRS
EX-10.9
51hp5rqu2mv wx4u7gdl
5 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next